Treatment Of Substance Use Disorders

Treatment of Substance Use Disorders

Substance use disorders (SUDs), particularly alcohol-related disorders, are among the most prevalent mental health concerns, yet a small percentage of affected individuals seek or receive adequate treatment. The high recidivism rate underscores the chronic nature of these disorders and the challenges in achieving sustained recovery. Advances in genetic research reveal that variants in alcohol-metabolizing enzymes influence vulnerability to alcohol misuse, with certain populations such as women, Native Americans, Asians, and some Hispanic and Celtic groups being more susceptible. Despite these insights, debate continues over the most effective treatment modalities, particularly the efficacy of medication-assisted treatment (MAT) versus abstinence-based treatment (ABT).

This discussion focuses on developing a comprehensive, culturally sensitive treatment plan for an individual with a substance use disorder, integrating clinical assessment, diagnosis, engagement strategies, and resource referral, in line with current psycho-social and medical approaches.

Paper For Above instruction

In approaching the case of Kaylin, a 22-year-old college student presenting with problematic alcohol use, it is crucial to establish an accurate diagnosis based on the DSM-5 criteria. After careful assessment of her symptoms—particularly her regular weekend alcohol consumption, symptoms of withdrawal such as morning tremors and nausea, and her inability to abstain or limit intake—she meets criteria for Alcohol Use Disorder (AUD) with moderate severity.

The DSM-5 diagnosis is: Alcohol Use Disorder, Moderate (ICD-10-CM F10.10). This diagnosis reflects her ongoing pattern of alcohol consumption leading to clinically significant impairment, characterized by hazardous drinking behavior, such as consuming alcohol to mitigate withdrawal symptoms and experiencing withdrawal symptoms like tremors and nausea. Her reports of increased drinking frequency, missed classes due to tiredness and sleep disturbance, and physical dependence signs substantiate the diagnosis. The presence of mild withdrawal symptoms and continued use despite negative consequences further affirm this condition.

To validate this diagnosis, I would employ structured assessments like the Alcohol Use Disorders Identification Test (AUDIT) and the Clinical Institute Withdrawal Assessment (CIWA-Ar). The AUDIT provides a comprehensive measure of her recent alcohol consumption, dependence symptoms, and alcohol-related harms, while the CIWA-Ar helps monitor withdrawal severity. Additionally, a physical exam and laboratory tests including liver function tests (LFTs), complete blood count (CBC), and carbohydrate-deficient transferrin (CDT) would serve as objective measures of her alcohol use severity and physical health impact. Longitudinal monitoring with these tools will also track her progress over time.

In explaining her diagnosis to Kaylin, I would emphasize that her symptoms—such as cravings, withdrawal signs, and continued drinking despite adverse effects—fit the clinical criteria for moderate alcohol use disorder. I would highlight that her pattern of use has begun to interfere with her academic responsibilities, health, and well-being, but that her recognition of these issues is an important first step towards recovery. I would reassure her that AUD is a manageable condition with appropriate treatment and support.

Engaging Kaylin requires a culturally sensitive approach that recognizes her background as the daughter of Korean immigrants and her current life stressors. Building rapport through empathetic listening, validating her experiences, and discussing her cultural values around health and family can foster trust. Understanding her social context, including her college environment, peer influences, and academic pressures, will inform tailored interventions. Addressing stigma related to substance use within her cultural community is also crucial to reduce barriers to treatment engagement.

Initial treatment recommendations should include a combination of psychoeducation, motivational interviewing, and both pharmacological and behavioral interventions. Given her physical dependence signs, medication-assisted treatment (MAT) with naltrexone or acamprosate could be beneficial to reduce cravings and prevent relapse. Abstinence-based strategies, including participation in peer support groups like Alcoholics Anonymous, can complement pharmacotherapy. Considering her age and lifestyle, a flexible, supportive, and goal-oriented treatment plan would foster sustained engagement.

Resources to support Kaylin include campus-based counseling services, local addiction treatment programs, and culturally tailored support groups, possibly incorporating Korean community resources to address cultural attitudes towards alcohol. Referrals to a psychiatrist specializing in addiction medicine would facilitate medication management. Additionally, integrating family support or educating her family about AUD can enhance her recovery environment. Given her college setting, peer support programs and academic accommodations might also be beneficial in reducing stressors contributing to her substance use.

These resources and treatment strategies are selected based on her diagnosis of moderate AUD, her current physical and psychological needs, and her cultural and social context. A comprehensive and culturally sensitive approach increases the likelihood of successful recovery by addressing individual, social, and systemic factors influencing her substance use behaviors.

References

• American Psychiatric Association. (2013). Diagnostic and statistical manual of mental disorders (5th ed.).
• Conway, K. P., & Compton, W. M. (2016). Epidemiology of substance use disorders. In S. M. Silverstein (Ed.), Principles of addiction medicine (pp. 25-33). American Society of Addiction Medicine.
• Hasin, D. S., O'Brien, C. P., & Huang, B. (2013). DSM-5 criteria for substance use disorder: Recommendations and implications. Addiction, 108(5), 841–846.
• Ketris, B., & Buchman, D. (2020). Cultural considerations in addiction treatment. Journal of Ethnicity in Substance Abuse, 19(3), 376-391.
• Miller, W. R., & Rollnick, S. (2013). Motivational interviewing: Helping people change (3rd ed.). Guilford Press.
• SAMHSA. (2020). Treatment Improvement Protocol (TIP) 63: Medications for Opioid Use Disorder. Substance Abuse and Mental Health Services Administration.
• Schuckit, M. A. (2014). Treatment of alcohol dependence. New England Journal of Medicine, 371(24), 2349-2358.
• Volkow, N. D., & Koob, G. F. (2015). The neuroscience of addiction: From molecules to behavior. Neuropharmacology, 76, 3–13.
• World Health Organization. (2018). Management of substance use disorders. WHO Press.
• Zahr, N. M., & Nunes, E. V. (2018). Alcohol use disorder and neurobiology. Journal of Neuropsychiatry and Clinical Neurosciences, 30(4), 271-282.